Oct 29 (Reuters) - Transition Therapeutics Inc TTH.TO :
* Announces agreement for phase 2 study of tt701 drug candidate
* Entered into an agreement for an investigator-led clinical study of drug
candidate, tt701, with brigham and women's hospital
* Says phase 2 study is scheduled to commence in calendar Q4 2015
* Source text for Eikon urn:newsml:reuters.com:*:nPn2Rg2HR
* Further company coverage TTH.TO